1. Increased DCLK1 correlates with the malignant status and poor outcome in malignant tumors: a meta-analysis
   Wenhua Shi et al, 2017, Oncotarget CrossRef
2. Pleiotropic effects of DCLK1 in cancer and cancer stem cells
   Dibyashree Chhetri et al, 2022, Frontiers in Molecular Biosciences CrossRef
3. Inhibition of DCLK1 with DCLK1-IN-1 Suppresses Renal Cell Carcinoma Invasion and Stemness and Promotes Cytotoxic T-Cell-Mediated Anti-Tumor Immunity
   Ling Ding et al, 2021, Cancers CrossRef
4. Tuft and Cancer Stem Cell Marker DCLK1: A New Target to Enhance Anti-Tumor Immunity in the Tumor Microenvironment
   Zhiyun Cao et al, 2020, Cancers CrossRef
5. Molecular Mechanisms of Epithelial to Mesenchymal Transition Regulated by ERK5 Signaling
   Akshita B. Bhatt et al, 2021, Biomolecules CrossRef
6. Clinical Significance and Regulation of ERK5 Expression and Function in Cancer
   Matilde Monti et al, 2022, Cancers CrossRef